Diabetes Mellitus  >>  autologous hematopoietic stem cell therapy  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
autologous hematopoietic stem cell therapy / Northwestern University
NCT00315133: Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

Completed
1/2
25
RoW
Immunosuppression and autologous stem cell transplantation
University of Sao Paulo, Northwestern University, Genzyme, a Sanofi Company
Type 1 Diabetes Mellitus
12/10
12/14
NCT01285934: Hematopoietic Stem Cell Support Versus Insulin in T1D

Withdrawn
1/2
0
US
Autologous Hematopoietic Stem Cell Transplantation, intensive insulin therapy, IIT
Northwestern University, University of Sao Paulo General Hospital
Diabetes Mellitus, Type 1
08/15
08/15

Download Options